Christopher R. Garrett
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Gastrointestinal Tumor Research and Treatment, Gastric Cancer Management and Outcomes, Pancreatic and Hepatic Oncology Research, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial(2006)2,585 cited
- → Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab(2007)1,126 cited
- → High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome(2011)391 cited
- → Surgical Strategies for Synchronous Colorectal Liver Metastases in 156 Consecutive Patients: Classic, Combined or Reverse Strategy?(2010)274 cited
- → Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment(2015)248 cited
- → Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin(2008)239 cited
- → Malignant Pleural Mesothelioma: A Comprehensive Review(2006)197 cited
- → Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer(2012)153 cited
- → A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing(2007)149 cited
- → Progression-Free Survival Remains Poor Over Sequential Lines of Systemic Therapy in Patients With BRAF-Mutated Colorectal Cancer(2014)135 cited